As our friend Howard Wolinsky continues his journalistic exploits into the world of prostate cancer, he has (almost inevitably) come across an issue of “conflicts of interest”, … READ MORE …
Filed under: Uncategorized | Tagged: 4Kscore, conflict, interest, phi, test | 1 Comment »
The Intergroupe Coopérateur Francophone de Recherche en Onco-urologie (ICFuro) has just published a review of the available evidence on the clinical validity and utility of six prognostic biomarkers available for the assessment of prostate cancer-related risk. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: 4Kscore, Decipher, GPS, MiPS, Oncotype, phi, prognosis, PROLARIS, review, test | 4 Comments »
According to data from a large, prospective, multi-institutional trial carried out here in the USA, the 4KScore test has shown a high degree of ability to accurately identify men with a Gleason score of 3 + 4 = 7 or higher which was subsequently confirmed on prostate biopsy. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: 4Kscore, accuracy, Diagnosis, kallikrein, risk, test | 4 Comments »
We now have five approved tests that can (at least in theory) help a man — and his doctors — to decide whether he is at sufficient risk for clinically significant prostate cancer that he should go get a biopsy. But how good are they really? … READ MORE …
Filed under: Diagnosis, Risk | Tagged: 4Kscore, free, MRI, multi-parametric, PCA3, phi, PSA | 5 Comments »
The late-breaking abstract for the results of a US-based study of the accuracy of the new 4Kscore Test™ has just been made available on line. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: 4Kscore, accuracy, biopsy, value | 1 Comment »
According to a media release on the OPKO corporate web site, the company is now starting to carry out its previously discussed 4Kscore test for urologists and their patients here in the USA through its CLIA-accredited laboratory in Nashville, Tennessee. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: 4Kscore, Diagnosis, risk, test | 5 Comments »
According to a media release on the company’s web site, OPKO Health has completed the acquisition of Prost-Data, Inc. (otherwise known to many prostate cancer patients and support group leaders — as well as their urologists — as Jonathon Oppenheimer’s independent uropathology company OURLab). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: 4Kscore, Diagnosis, kallikrein, OPKO, OurLab, PSA, risk, test | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 